Atlas company financials

Elanco Animal Health Inc

Standardized 10-year financial series for Elanco Animal Health Inc, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001739104FY2016 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$4.7B

Adjusted EBITDA

—

Net result

-$232M

Net financial debt

$3.2B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$1.1B

TTM revenue

$4.6B

TTM free cash flow

—

Latest quarter net result

-$34M

Quarterly coverage: 25 periods · latest quarter FY2025-Q3 · TTM revenue growth 1.9%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · elanco-animal-health-inc-fy2016 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2019-02-20 · Retrieved: 2026-04-26T11:47:24.608143+00:00
SEC EDGAR companyfacts
us-gaap:EarningsPerShareBasic · us gaap companyfacts · comparative · elanco-animal-health-inc-fy2017 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2020-02-28 · Retrieved: 2026-04-26T11:47:24.608143+00:00
SEC EDGAR companyfacts
primary · elanco-animal-health-inc-fy2020 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2021-03-01 · Retrieved: 2026-04-26T11:47:24.608143+00:00
SEC EDGAR companyfacts
primary · elanco-animal-health-inc-fy2021 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2022-02-28 · Retrieved: 2026-04-26T11:47:24.608143+00:00
SEC EDGAR companyfacts
primary · elanco-animal-health-inc-fy2022 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2023-03-01 · Retrieved: 2026-04-26T11:47:24.608143+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2016	3B	—	—	-48M	156M	-110M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing basic eps · missing cash and cash equivalents · missing current assets · missing current liabilities · missing diluted eps · missing diluted weighted average shares · missing ebit · missing gross profit · missing inventory · missing net financial debt · missing total assets
FY2017	3B	—	—	-311M	174M	-99M	-323M	comparative annual fact carried from later 10k · missing adjusted ebitda · missing ebit · missing gross profit
FY2018	3B	—	—	87M	487M	-135M	2B	missing adjusted ebitda · missing ebit · missing gross profit
FY2019	3B	—	—	68M	224M	-140M	2B	missing adjusted ebitda · missing ebit · missing gross profit
FY2020	3B	—	—	-560M	-41M	-135M	6B	missing adjusted ebitda · missing ebit · missing gross profit
FY2021	5B	—	—	-472M	483M	-126M	6B	missing adjusted ebitda · missing ebit · missing gross profit
FY2022	4B	—	—	-78M	452M	-137M	5B	missing adjusted ebitda · missing ebit · missing gross profit
FY2023	4B	—	—	-1B	271M	-140M	5B	missing adjusted ebitda · missing ebit
FY2024	4B	—	—	338M

Filing provenance